Elaprase 2 mg/ml, Infusionskonzentrat

7680579160010 CH-57916 Infusionskonzentrat
Elaprase 2 mg/ml, Infusionskonzentrat
Elaprase 2 mg/ml, Infusionskonzentrat
Elaprase 2 mg/ml, Infusionskonzentrat
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Infusionskonzentrat
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/10/2025
Summary of Product Characteristics
Français
17/10/2025
Summary of Product Characteristics
Italien
17/10/2025
Patient information leaflet
Allemand
05/07/2022
Patient information leaflet
Français
05/07/2022
Patient information leaflet
Italien
05/07/2022

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.7 MG Substance HBESI

Reimbursement information

Public price
CHF 2822.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2025

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
57916
Drug name
Elaprase, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
A16AB09
Authorization status
Z
Dispensing category
A
First authorization
20/03/2007
Authorization expiration date
31/12/9999
IT Number
07.14.0.
Domain
Human medicine
Field of application
Langzeitbehandlung von Patienten mit Hunter-Syndrom (Mukopolysaccharidose II, MPS II)

Package details

Description (FR)
ELAPRASE conc perf 6 mg/3ml flac 3 ml
Description (DE)
ELAPRASE Inf Konz 6 mg/3ml Durchstf 3 ml
Market launch
20/03/2007
Narcotic (BTM)
No